Skip to main content
Industry News
RefleXion, HealthMyne enter cancer radiomics partnership
1/11/2021

RefleXion Medical and HealthMyne have entered a partnership deal enabling the use of HealthMyne's radiomics and image analysis algorithms to evaluate Reflexion biology-guided radiotherapy system-derived PET and CT data to develop personalized radiation therapy based on patients' tumor characteristics and radiotherapy response. Such therapies will be more beneficial in cancer treatment, compared with standard protocol-based radiotherapy, according to the companies.

Full Story: